Literature DB >> 24062236

Accumulation of carbapenem resistance mechanisms in VIM-2-producing Pseudomonas aeruginosa under selective pressure.

G Meletis1, N Vavatsi, M Exindari, E Protonotariou, E Sianou, C Haitoglou, D Sofianou, S Pournaras, E Diza.   

Abstract

Pseudomonas aeruginosa has the potential to achieve resistance to carbapenems via the acquisition of carbapenemase-encoding genes, the downregulation of the OprD porin, the overexpression of efflux systems and the overproduction of cephalosporinases. One hundred and fifty carbapenem-non-susceptible isolates from 2008 to 2010 were screened for carbapenemase production, OprD porin loss, efflux pumps overexpression and inducible AmpC beta-lactamase production. For comparison reasons, the presence of the same mechanisms was also assessed in a previous collection of 30 carbapenem-non-susceptible P. aeruginosa isolated between 2003 and 2005. Results showed the accumulation of various resistance mechanisms among VIM-2 producers isolated between 2008 and 2010 with a parallel considerable increase in imipenem MIC90 and the geometric mean of the MIC values of imipenem and meropenem between the two study groups. The accumulation of carbapenem resistance mechanisms highlights the potential of this formidable pathogen for evolutionary success under antibiotic selective pressure.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24062236     DOI: 10.1007/s10096-013-1952-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  24 in total

1.  First report of a Pseudomonas aeruginosa clinical isolate co-harbouring KPC-2 and IMP-18 carbapenemases.

Authors:  Teresa Martínez; Guillermo J Vázquez; Edna E Aquino; Ramón Ramírez-Ronda; Iraida E Robledo
Journal:  Int J Antimicrob Agents       Date:  2012-04-20       Impact factor: 5.283

2.  Detection of extended-spectrum beta-lactamases in clinical isolates of Pseudomonas aeruginosa.

Authors:  Xiaofei Jiang; Zhe Zhang; Min Li; Danqiu Zhou; Feiyi Ruan; Yuan Lu
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

3.  Emerging Klebsiella pneumoniae isolates coproducing KPC-2 and VIM-1 carbapenemases.

Authors:  Panagiota Giakkoupi; Olga Pappa; Michalis Polemis; Alkiviadis C Vatopoulos; Vivi Miriagou; Anastasia Zioga; Costas C Papagiannitsis; Leonidas S Tzouvelekis
Journal:  Antimicrob Agents Chemother       Date:  2009-07-06       Impact factor: 5.191

Review 4.  The challenges of antimicrobial drug resistance in Greece.

Authors:  Spiros Miyakis; Angelos Pefanis; Athanassios Tsakris
Journal:  Clin Infect Dis       Date:  2011-07-15       Impact factor: 9.079

5.  First report of a Pseudomonas aeruginosa isolate coharboring KPC and VIM carbapenemases.

Authors:  A Correa; M C Montealegre; M F Mojica; J J Maya; L J Rojas; E P De La Cadena; S J Ruiz; M Recalde; F Rosso; J P Quinn; M V Villegas
Journal:  Antimicrob Agents Chemother       Date:  2012-07-23       Impact factor: 5.191

6.  Emergence of Klebsiella pneumoniae carrying bla(VIM) and bla(KPC) genes.

Authors:  G Meletis; E Tzampaz; E Protonotariou; D Sofianou
Journal:  Hippokratia       Date:  2010-04       Impact factor: 0.471

7.  Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates.

Authors:  John Quale; Simona Bratu; Jyoti Gupta; David Landman
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

8.  Use of several inducer and substrate antibiotic combinations in a disk approximation assay format to screen for AmpC induction in patient isolates of Pseudomonas aeruginosa, Enterobacter spp., Citrobacter spp., and Serratia spp.

Authors:  W Michael Dunne; Daniel J Hardin
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

Review 9.  Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance.

Authors:  Neil Woodford; Jane F Turton; David M Livermore
Journal:  FEMS Microbiol Rev       Date:  2011-03-01       Impact factor: 16.408

10.  Pseudomonas aeruginosa: resistance to the max.

Authors:  Keith Poole
Journal:  Front Microbiol       Date:  2011-04-05       Impact factor: 5.640

View more
  8 in total

Review 1.  Double- and multi-carbapenemase-producers: the excessively armored bacilli of the current decade.

Authors:  G Meletis; D Chatzidimitriou; N Malisiovas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-18       Impact factor: 3.267

Review 2.  Carbapenem resistance: overview of the problem and future perspectives.

Authors:  Georgios Meletis
Journal:  Ther Adv Infect Dis       Date:  2016-02

3.  Phenotypic and genotypic detection of antibiotic resistance of Pseudomonas aeruginosa isolated from urinary tract infections.

Authors:  Hisham A Abbas; Amira M El-Ganiny; Hend A Kamel
Journal:  Afr Health Sci       Date:  2018-03       Impact factor: 0.927

4.  In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa.

Authors:  Katherine Young; Ronald E Painter; Susan L Raghoobar; Nichelle N Hairston; Fred Racine; Douglas Wisniewski; Carl J Balibar; Artjohn Villafania; Rumin Zhang; Daniel F Sahm; Timothy Blizzard; Nicholas Murgolo; Milton L Hammond; Mary R Motyl
Journal:  BMC Microbiol       Date:  2019-07-04       Impact factor: 3.605

Review 5.  JMM Profile: Carbapenems: a broad-spectrum antibiotic.

Authors:  Tom Armstrong; Samuel Jacob Fenn; Kim R Hardie
Journal:  J Med Microbiol       Date:  2021-12       Impact factor: 2.472

6.  Role of the Outer Membrane Protein OprD2 in Carbapenem-Resistance Mechanisms of Pseudomonas aeruginosa.

Authors:  Jilu Shen; Yaping Pan; Yaping Fang
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

7.  MULTILOCUS SEQUENCE TYPING OF CARBAPENEM RESISTANT PSEUDOMONAS AERUGINOSA ISOLATES FROM PATIENTS PRESENTING AT PORT ELIZABETH HOSPITALS, SOUTH AFRICA.

Authors:  D Annear; J Black; S Govender
Journal:  Afr J Infect Dis       Date:  2017-06-08

8.  Eight-year trends in the relative isolation frequency and antimicrobial susceptibility among bloodstream isolates from Greek hospitals: data from the Greek Electronic System for the Surveillance of Antimicrobial Resistance - WHONET-Greece, 2010 to 2017.

Authors:  Michalis Polemis; Kyriaki Tryfinopoulou; Panagiota Giakkoupi; Alkiviadis Vatopoulos
Journal:  Euro Surveill       Date:  2020-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.